JFL Life Sciences Ltd

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 9.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.47% on 05 May 2026, with buyers queuing and no sellers willing to part with shares.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 9.15, sellers were still queuing — but there were no buyers willing to take the other side. JFL Life Sciences Ltd locked at its lower circuit of 4.69% on 20 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 8.95, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.68% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 8.55, JFL Life Sciences Ltd locked at its lower circuit on 2 Apr 2026, reflecting a 4.47% decline within a 5% price band. Sellers were lined up to exit, but no buyers emerged to absorb the supply, resulting in a frozen price and unfilled sell orders.

At Rs 8.95, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.68% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

At Rs 9.5, sellers were still queuing — but there were no buyers willing to take the other side. JFL Life Sciences Ltd locked at its lower circuit of 4.52% on 23 Mar 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit price limit on 18 Mar 2026, registering a maximum daily gain of 4.66%. This sharp price movement was driven by robust buying interest, resulting in a regulatory freeze on further trading and highlighting significant unfilled demand in the stock.

JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 16 Mar 2026, hitting its lower circuit price limit of ₹9.75. The stock recorded a maximum daily loss of 4.88%, underperforming its sector by 3.51% and reflecting intense selling pressure and panic among investors.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Shares of JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to their lower circuit limit on 13 Mar 2026, closing at ₹10.25, down 4.65% on the day. The stock’s sharp decline reflects intense selling pressure and panic among investors, with volumes and turnover indicating a significant imbalance between supply and demand.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 5 Mar 2026, closing at ₹10.45, marking a maximum daily loss of 4.57%. The stock’s sharp decline reflects intense selling pressure and panic among investors, with volumes remaining subdued and supply largely unfilled, signalling a challenging outlook for this micro-cap pharmaceutical player.

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 20 Feb 2026, closing at ₹10.40, marking a maximum daily loss of 4.59%. The micro-cap pharmaceutical stock faced intense selling pressure, with volumes rising amid panic selling and unfilled supply, signalling deep investor concerns despite the sector’s modest gains.